Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q1 FY20 results · Apr–Jun 2019
Wockhardt reported revenue from operations of ₹863.11 crore (down 14.3% from Q1 FY19) and net loss of ₹36.88 crore for Q1 FY20 (Apr–Jun 2019), on a consolidated basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 863.11 | 1,007.71 | −14.3% | 979.13 | −11.8% |
| Other income | 8.08 | 7.43 | +8.7% | 5.42 | +49.1% |
| Total income | 871.19 | 1,015.14 | −14.2% | 984.55 | −11.5% |
| Profit before tax | (77.86) | (99.94) | Loss narrowed | (48.00) | Loss widened |
| Net profit for the period | (36.88) | (95.06) | Loss narrowed | (13.90) | Loss widened |
| EPS, basic (₹) | (4.06) | (7.79) | Loss narrowed | (1.31) | Loss widened |
| Net margin (%) | -4.3 | -9.4 | -1.4 |
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 352.21 | 539.36 | −34.7% | 467.40 | −24.6% |
| Other income | 8.61 | 8.33 | +3.4% | 8.39 | +2.6% |
| Total income | 360.82 | 547.69 | −34.1% | 475.79 | −24.2% |
| Profit before tax | (133.18) | (16.88) | Loss widened | (82.73) | Loss widened |
| Net profit for the period | (82.93) | (15.11) | Loss widened | (33.52) | Loss widened |
| EPS, basic (₹) | (7.49) | (1.37) | Loss widened | (3.03) | Loss widened |
| Net margin (%) | -23.5 | -2.8 | -7.2 |
Consolidated
- Filed with BSE
- 14 Aug 2019, 16:53 IST
- Board meeting
- 14 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Aug 2019, 16:53 IST
- Board meeting
- 14 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE